CRC has an immunosuppressive TME which stops the development of a good response to ICB therapies. There exists Therefore an urgent must determine the techniques reprogram this suppressive TME in an effort to enrich immunotherapy efficacy. In The present analyze, we made use of CRISPR KO screens to find out https://scottj307zfj1.csublogs.com/profile